Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

Cynthia Wright, Sahar Sibani, David Trudgian, Roman Fischer, Benedikt Kessler, Joshua LaBaer, Paul Bowness

Research output: Contribution to journalArticle

Abstract

Ankylosing spondylitis (AS) is a common, inflammatory rheumatic disease that primarily affects the axial skeleton and is associated with sacroiliitis, uveitis, and enthesitis. Unlike other autoimmune rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus, autoantibodies have not yet been reported to be a feature of AS. We therefore wished to determine whether plasma from patients with AS contained autoantibodies and, if so, characterize and quantify this response in comparison to patients with rheumatoid arthritis (RA) and healthy controls. Two high density nucleic acid programmable protein arrays expressing a total of 3498 proteins were screened with plasma from 25 patients with AS, 17 with RA, and 25 healthy controls. Autoantigens identified were subjected to Ingenuity Pathway Analysis to determine the patterns of signaling cascades or tissue origin. 44% of patients with ankylosing spondylitis demonstrated a broad autoantibody response, as compared with 33% of patients with RA and only 8% of healthy controls. Individuals with AS demonstrated autoantibody responses to shared autoantigens, and 60% of autoantigens identified in the AS cohort were restricted to that group. The autoantibody responses in the AS patients were targeted toward connective, skeletal, and muscular tissue, unlike those of RA patients or healthy controls. Thus, patients with AS show evidence of systemic humoral autoimmunity and multispecific autoantibody production. Nucleic acid programmable protein arrays constitute a powerful tool to study autoimmune diseases.

Original languageEnglish (US)
JournalMolecular & cellular proteomics : MCP
Volume11
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

Protein Array Analysis
Ankylosing Spondylitis
Autoantibodies
Nucleic Acids
Autoantigens
Rheumatoid Arthritis
Proteins
Tissue
Rheumatic Diseases
Plasmas
Autoimmune Diseases
Sacroiliitis
Uveitis
Autoimmunity
Skeleton
Systemic Lupus Erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. / Wright, Cynthia; Sibani, Sahar; Trudgian, David; Fischer, Roman; Kessler, Benedikt; LaBaer, Joshua; Bowness, Paul.

In: Molecular & cellular proteomics : MCP, Vol. 11, No. 2, 02.2012.

Research output: Contribution to journalArticle

Wright, Cynthia ; Sibani, Sahar ; Trudgian, David ; Fischer, Roman ; Kessler, Benedikt ; LaBaer, Joshua ; Bowness, Paul. / Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. In: Molecular & cellular proteomics : MCP. 2012 ; Vol. 11, No. 2.
@article{317165c6cbd7443aaaaa24d4b1fc8f88,
title = "Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.",
abstract = "Ankylosing spondylitis (AS) is a common, inflammatory rheumatic disease that primarily affects the axial skeleton and is associated with sacroiliitis, uveitis, and enthesitis. Unlike other autoimmune rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus, autoantibodies have not yet been reported to be a feature of AS. We therefore wished to determine whether plasma from patients with AS contained autoantibodies and, if so, characterize and quantify this response in comparison to patients with rheumatoid arthritis (RA) and healthy controls. Two high density nucleic acid programmable protein arrays expressing a total of 3498 proteins were screened with plasma from 25 patients with AS, 17 with RA, and 25 healthy controls. Autoantigens identified were subjected to Ingenuity Pathway Analysis to determine the patterns of signaling cascades or tissue origin. 44{\%} of patients with ankylosing spondylitis demonstrated a broad autoantibody response, as compared with 33{\%} of patients with RA and only 8{\%} of healthy controls. Individuals with AS demonstrated autoantibody responses to shared autoantigens, and 60{\%} of autoantigens identified in the AS cohort were restricted to that group. The autoantibody responses in the AS patients were targeted toward connective, skeletal, and muscular tissue, unlike those of RA patients or healthy controls. Thus, patients with AS show evidence of systemic humoral autoimmunity and multispecific autoantibody production. Nucleic acid programmable protein arrays constitute a powerful tool to study autoimmune diseases.",
author = "Cynthia Wright and Sahar Sibani and David Trudgian and Roman Fischer and Benedikt Kessler and Joshua LaBaer and Paul Bowness",
year = "2012",
month = "2",
doi = "10.1074/mcp.M9.00384",
language = "English (US)",
volume = "11",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

AU - Wright, Cynthia

AU - Sibani, Sahar

AU - Trudgian, David

AU - Fischer, Roman

AU - Kessler, Benedikt

AU - LaBaer, Joshua

AU - Bowness, Paul

PY - 2012/2

Y1 - 2012/2

N2 - Ankylosing spondylitis (AS) is a common, inflammatory rheumatic disease that primarily affects the axial skeleton and is associated with sacroiliitis, uveitis, and enthesitis. Unlike other autoimmune rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus, autoantibodies have not yet been reported to be a feature of AS. We therefore wished to determine whether plasma from patients with AS contained autoantibodies and, if so, characterize and quantify this response in comparison to patients with rheumatoid arthritis (RA) and healthy controls. Two high density nucleic acid programmable protein arrays expressing a total of 3498 proteins were screened with plasma from 25 patients with AS, 17 with RA, and 25 healthy controls. Autoantigens identified were subjected to Ingenuity Pathway Analysis to determine the patterns of signaling cascades or tissue origin. 44% of patients with ankylosing spondylitis demonstrated a broad autoantibody response, as compared with 33% of patients with RA and only 8% of healthy controls. Individuals with AS demonstrated autoantibody responses to shared autoantigens, and 60% of autoantigens identified in the AS cohort were restricted to that group. The autoantibody responses in the AS patients were targeted toward connective, skeletal, and muscular tissue, unlike those of RA patients or healthy controls. Thus, patients with AS show evidence of systemic humoral autoimmunity and multispecific autoantibody production. Nucleic acid programmable protein arrays constitute a powerful tool to study autoimmune diseases.

AB - Ankylosing spondylitis (AS) is a common, inflammatory rheumatic disease that primarily affects the axial skeleton and is associated with sacroiliitis, uveitis, and enthesitis. Unlike other autoimmune rheumatic diseases, such as rheumatoid arthritis or systemic lupus erythematosus, autoantibodies have not yet been reported to be a feature of AS. We therefore wished to determine whether plasma from patients with AS contained autoantibodies and, if so, characterize and quantify this response in comparison to patients with rheumatoid arthritis (RA) and healthy controls. Two high density nucleic acid programmable protein arrays expressing a total of 3498 proteins were screened with plasma from 25 patients with AS, 17 with RA, and 25 healthy controls. Autoantigens identified were subjected to Ingenuity Pathway Analysis to determine the patterns of signaling cascades or tissue origin. 44% of patients with ankylosing spondylitis demonstrated a broad autoantibody response, as compared with 33% of patients with RA and only 8% of healthy controls. Individuals with AS demonstrated autoantibody responses to shared autoantigens, and 60% of autoantigens identified in the AS cohort were restricted to that group. The autoantibody responses in the AS patients were targeted toward connective, skeletal, and muscular tissue, unlike those of RA patients or healthy controls. Thus, patients with AS show evidence of systemic humoral autoimmunity and multispecific autoantibody production. Nucleic acid programmable protein arrays constitute a powerful tool to study autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=84861692591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861692591&partnerID=8YFLogxK

U2 - 10.1074/mcp.M9.00384

DO - 10.1074/mcp.M9.00384

M3 - Article

VL - 11

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 2

ER -